Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? Equity (Details Narrative)

v3.25.1
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Aug. 06, 2024
Apr. 29, 2024
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares of common stock   350,000    
Capital investment, value   $ 3,850 $ 4,007  
Issuance costs   $ 66    
Warrant exercise price   $ 11.00    
Beneficiary ownership limitation percentage   9.99%    
Commission rate 3.00%      
Net proceeds     4,007
Sales Agreement        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Net proceeds     438  
Other related expenses     $ 18  
Common Stock        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares of common stock [1]     488,188  
Capital investment, value     $ 4  
Common Stock | Sales Agreement        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Shares of common stock     138,988  
[1] Adjusted retroactively to reflect the 1-for-10 reverse stock split that became effective on July 17, 2024, see Note 1.